Autoimmune conditions
Early diffuse cutaneous systemic sclerosis
Early diffuse cutaneous systemic sclerosis is a form of systemic autoimmune disease involving blood vessels, skin thickening and potentially internal-organ fibrosis. It is distinct from localized scleroderma and from other systemic-sclerosis patterns.
Other names and abbreviations
SSc · dcSSc · early dcSSc · systemic scleroderma · scleroderma · systemic sclerosis · Systemic sclerosis · Scleroderma · Progressive systemic sclerosis · Diffuse cutaneous systemic sclerosis
Where transplant fits
Autologous transplantation is an established option for carefully selected patients with severe, progressive disease. It uses the patient’s own stem cells, not a registry donor. Detailed heart and lung assessment is crucial because treatment can be dangerous in advanced organ disease.
Treatment depends on the exact diagnosis, disease stage, prior treatment and the person’s health. These categories are not estimates of donor demand.
Treatment at a glance
- Who it affects
- The disease more often affects adults, particularly women, but the transplant evidence concerns a selected severe progressive subgroup rather than all systemic sclerosis.
- Other treatment options
- Immune-directed medicines and organ-specific treatment address skin, lung, vascular, gastrointestinal and other complications. Treatment is tailored to the pattern of disease.
- Cells used for transplantation
- When performed, transplantation uses the patient’s own blood-forming stem cells, usually collected from peripheral blood.
Why the details matter
Benefit in trials does not mean every patient is eligible. Early treatment risk, existing organ damage and alternatives must be weighed individually.
How a transplant using your own cells works
Questions to bring to your care team
What is the exact diagnosis or subtype? What is the goal of each treatment option? If transplant is being considered, why does it fit this situation, which cells would be used and what are the alternatives?
Sources and further reading
- Scleroderma
NIAMS, NIH · Accessed 2026-09-05 - Autoimmune Disease
EBMT Handbook · 2024-04-11 - 2025 EBMT practice recommendations for transplantation and CAR-T
EBMT · 2025
Understanding can become action.
Some patients need a blood stem cell donor. Others receive different treatment. Wherever your interest began, you can help JBF reach more people who may be able to donate.
Explore the official registry serving where you live. It explains who can join, how registration works and what donation involves.
Find your official registryIf joining is not right for you, a gift to the Jada Bascom Foundation supports education, outreach and referrals to official registries.
Donate to JBFKeep learning
Why matching is hard: an interactive leukemia story
More in autoimmune conditions. Sharing a group does not mean sharing a treatment plan.
